TY  - JOUR 
AU  - Díaz Rodríguez, María Elena
AU  - Pérez-Peña, Javier
AU  - Ríos Luci, Carla
AU  - Arribas, Joaquín
AU  - Ocaña, Alberto
AU  - Pandiella Alonso, Atanasio
PY  - 2019
UR  - http://hdl.handle.net/10366/171372
AB  - [EN]The appearance of resistance to the anti-HER2 targeted drug trastuzumab constitutes, nowadays, an important challenge in the oncology clinic. To fight such resistance, we searched for potential vulnerabilities in cells resistant to that drug. To...
LA  - eng
PB  - Elsevier
KW  - Apoptosis
KW  - HER2
KW  - TRAIL
KW  - Trastuzumab
KW  - Breast Neoplasms
KW  - Transcriptome
KW  - Recombinant Proteins
KW  - Drug Resistance
KW  - TNF-Related Apoptosis-Inducing Ligand
KW  - Apoptosis
KW  - HEK293 Cells
KW  - Humans
KW  - Signal Transduction
KW  - Cell Line
KW  - Antineoplastic Agents
TI  - TRAIL receptor activation overcomes resistance to trastuzumab in HER2 positive breast cancer cells
DO  - 10.1016/j.canlet.2019.03.042
T2  - Cancer letters
VL  - 453
M2  - 34
ER  -